로딩 중…
지수 로딩 중…
제이엘케이
322510· KOSDAQ· Health Care· Health Care Equipment & Services
₩5,440+9.35%
2026-08-04
Financials
Valuation Metrics
제이엘케이's Market Cap is ₩1399B. At end of 2025 it was ₩1430B. Ranked #1019 of 2,436 in KR market (top 42%), #510 of 1,649 on KOSDAQ (top 31%), #35 of 96 in Health Care Equipment & Services (top 36%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 139.95B KRW | KR#1,019/2,436 Sec#35/96 |
| Revenue | 3.27B KRW | KR#2,372/2,436 Sec#94/96 |
| Net Income | -14.21B KRW | KR—/2,436 Sec—/96 |
| Total Assets | 72.29B KRW | KR#1,970/2,436 Sec#63/96 |
| Net Assets | 38.42B KRW | KR#2,039/2,436 Sec#73/96 |
| Employees | 83 | KR#1,770/2,436 Sec#67/96 |
| Value | ||
| P/B | 3.64x | KR#2,174/2,436 Sec#79/96 |
| P/S | 42.84x | KR#2,363/2,436 Sec#94/96 |
| Profitability | ||
| ROE | -36.98% | KR#2,217/2,436 Sec#81/96 |
| ROA | -19.65% | KR#2,228/2,436 Sec#78/96 |
| Op. Margin | -404.50% | KR#2,368/2,436 Sec#93/96 |
| Revenue Growth | -15.07% | KR#1,990/2,436 Sec#79/96 |
| Financial Health | ||
| Debt Ratio | 188.17% | KR#1,611/2,436 Sec#77/96 |
| Total Debt | 52.57B KRW | KR#967/2,436 Sec#23/96 |
| Cash | 4.94B KRW | KR#1,995/2,436 Sec#71/96 |
| Current Ratio | 1.97x | KR#965/2,436 Sec#51/96 |
| Performance | ||
| 1Y Return | -9.18% | KR#938/2,436 Sec#24/96 |
| 1M Return | 28.61% | KR#72/2,436 Sec#4/96 |
| From 52W High | -40.93% | KR#797/2,436 Sec#30/96 |
| 1Y MDD | -57.61% | KR#1,286/2,436 Sec#45/96 |
| Trading | ||
| Volume | 143,363 shares | KR#743/2,436 Sec#29/96 |
| Foreign Own. | 0.38% | KR—/2,436 Sec—/96 |
| Per Share | ||
| EPS | -556 KRW | KR—/2,436 Sec—/96 |
| BPS | 1,503 KRW | KR#2,157/2,436 Sec#76/96 |
Company Info
Established in 2014 and listed on KOSDAQ in 2019, JLK is a medical artificial intelligence solution specialized enterprise. Leveraging AI technology, the company offers early disease diagnosis, interpretation support, and lesion detection services through the analysis of medical images such as MRI, CT, and X-Ray. JLK is commercializing MEDIHUB STROKE and Cancer Solution, and is pursuing global expansion with 76 worldwide permits and approvals. The company is headquartered in Cheongju-si, Chungcheongbuk-do.